FDA Warns Novo Nordisk on Unreported Deaths CEO & Founder at LlamaLab FDA Cites 'Systemic Failures' in Novo Nordisk's Reporting of Ozempic Deaths The FDA issued a warning letter to Novo Nordisk on March 5, 2026, citing "systemic failures" in the company's adverse event reporting for its semaglutide and liraglutide drugs including at least two unreported patient deaths and a suicide case that had still not been submitted to the FDA as of the letter's date
5th (Wed) See Description Item Reviews (91) 5.0 out of 5 stars You can see more description If you click item image
Your specialist weight management team and GP should monitor your response, assess tolerability, and adjust management strategies as needed
PCOS causes symptoms such as irregular menstrual cycles, insulin resistance, hirsutism (excess hair growth, especially on the face think those pesky chin hairs!), acne, male pattern baldness, and anovulation
10.18632/aging.103504 130 SerakinciN.CagsinH.MavisM